Welcome to our dedicated page for Oracle SEC filings (Ticker: ORCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Oracle Corporation’s (ORCL) U.S. Securities and Exchange Commission filings, giving investors a primary source of information on the company’s governance, capital structure, and material events. Oracle’s common stock, par value $0.01 per share, is registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ORCL, as disclosed in multiple Forms 8‑K.
Among Oracle’s key filings are current reports on Form 8‑K, which document events such as quarterly financial results, cash dividend declarations, leadership and board changes, and significant financing transactions. Recent 8‑K filings describe press releases announcing fiscal quarter results, the declaration of cash dividends on Oracle’s common stock, the promotion of executives to Chief Executive Officer roles and Principal Financial Officer, the appointment and retirement of directors, and the issuance of senior notes under an existing shelf registration statement.
Oracle’s definitive proxy statement on Schedule 14A (DEF 14A) outlines matters for its annual meeting of stockholders, including the election of directors, an advisory vote on executive compensation, and ratification of its independent registered public accounting firm. The proxy statement also discusses board structure, committees, corporate governance guidelines, stock ownership policies, and executive compensation programs.
Investors may also find Form 25 filings relevant for specific Oracle debt securities. Oracle has filed a Form 25‑NSE relating to the removal from listing of its 3.125% Notes due 2025 from the New York Stock Exchange. This filing concerns a class of notes and is separate from the listing of Oracle’s common stock.
On Stock Titan, Oracle’s SEC filings are organized chronologically and can be paired with AI‑powered summaries that explain the purpose and implications of each document. This helps readers quickly understand items such as 8‑K event descriptions, proxy proposals, and capital markets transactions, while still allowing direct access to the full text of Oracle’s submissions to the SEC.
Oracle Corporation reports strong growth in its latest quarter. For the three months ended February 28, 2026, revenue rose to
For the nine months, revenue grew to
Oracle Corporation reported a strong fiscal Q3 2026 driven by rapid cloud growth and AI demand. Total revenue reached $17.2 billion, up 22% in USD, while cloud revenue rose 44% to $8.9 billion. GAAP earnings per share were $1.27, up 24%, and non-GAAP EPS were $1.79, up 21%.
Remaining performance obligations surged to $553 billion, up 325% year-over-year, largely from large-scale AI contracts. The company reaffirmed fiscal 2026 revenue guidance of $67 billion, raised fiscal 2027 revenue guidance to $90 billion, and projected Q4 2026 total revenue growth of 19%–21% in USD and total cloud growth of 46%–50% in USD.
Oracle is funding its AI expansion with heavy investment: fiscal 2026 capital expenditures are guided to $50 billion, trailing four-quarter free cash flow is negative, and the firm has begun a $50 billion financing program, already raising $30 billion via investment-grade bonds and mandatory convertible preferred stock. The board declared a quarterly dividend of $0.50 per common share and $1,263.89 per share on mandatory convertible preferred stock.
Oracle Corp Chief Executive Officer Clayton M. Magouyrk reported an open-market sale of 10,000 shares of Oracle common stock. The transaction occurred on February 9, 2026 at a weighted average price of $155.2318 per share, based on multiple trades between $155.23 and $155.28.
After this sale, Magouyrk directly owns 134,030 Oracle shares. The filing notes that detailed trade-by-trade price and share information is available upon request to Oracle, the SEC staff, or any Oracle shareholder.
Oracle Corporation insider Clayton Magouyrk has filed a Form 144 notice to sell 10,000 shares of Oracle common stock. The proposed sale, through Fidelity Brokerage Services on the NYSE around
The shares to be sold were acquired on
Oracle Corporation has set up an equity distribution agreement for an “at-the-market” stock offering of up to $20.0 billion of its common shares, to be sold from time to time through a syndicate of sales agents on the New York Stock Exchange and other venues. Oracle may also use forward sale arrangements and is not obligated to sell any shares.
Separately, Oracle completed the issuance of $25 billion in senior notes across multiple maturities from 2029 to 2066, with fixed coupons ranging from 4.550% to 6.850% plus a floating‑rate tranche. Net proceeds from these notes are earmarked for general corporate purposes, including potential capital spending, debt repayment, investments or acquisitions, and cash dividends or share repurchases.
Oracle Corporation is offering 100,000,000 depositary shares at $50 each, raising $5 billion gross (about $4.95 billion net before estimated expenses) through a new 6.50% Series D mandatory convertible preferred stock structure.
Each depositary share represents a 1/2,000th interest in a preferred share with a $100,000 liquidation preference (or $50 per depositary share). Dividends accrue at 6.50% annually on the liquidation preference and are payable quarterly in cash, Oracle common stock, or a mix of both, at Oracle’s discretion and subject to limits.
The preferred stock will automatically convert on or about January 15, 2029 into Oracle common shares at a variable rate between 499.8126 and 624.7657 shares per preferred share (0.2499–0.3124 per depositary share), based on the 20‑day volume‑weighted average price before maturity. Investors bear full downside exposure if the stock trades below the initial reference price and have capped upside participation above the threshold appreciation price.
Oracle plans to list the depositary shares on the NYSE under “ORCL-PRD” and expects to use proceeds for general corporate purposes. The deal is part of broader concurrent financing, including a separate $25 billion senior notes offering and a potential $20 billion at‑the‑market common stock program.
Oracle has a prospectus supplement covering the offer and sale of up to $20,000,000,000 of common stock from time to time through a group of investment banks acting as sales agents under an equity distribution agreement.
The supplement does not change the size of the program; it adds HSBC Securities (USA), BNP Paribas, PNC Capital Markets, SMBC Nikko, Santander US Capital Markets, TD Securities (USA), BNY Mellon Capital Markets, Credit Agricole Securities (USA), ING Financial Markets and Wells Fargo Securities as additional sales agents via a joinder agreement. Investors are directed to previously disclosed risk factors in Oracle’s earlier prospectus supplement and its Form 10‑K.
Oracle Corporation is offering $25,000,000,000 of senior unsecured notes in eight tranches with maturities from 2029 to 2066. The deal includes $500,000,000 floating-rate notes tied to Compounded SOFR plus 1.11%, and fixed-rate notes bearing coupons from 4.550% to 6.850%.
Oracle expects to receive approximately $24.9 billion in net proceeds, to be used for general corporate purposes such as capital spending, debt repayment, investments, acquisitions, and potential dividends or share repurchases. Concurrent but separate financings include a mandatory convertible preferred stock offering and an at-the-market common stock program of up to $20 billion.
Oracle Corporation has established an at-the-market equity program to sell up to $20 billion of its common stock from time to time through BofA Securities, Citigroup, Deutsche Bank, Goldman Sachs and J.P. Morgan as sales agents or principals.
Sales may be made on the NYSE or other venues at prevailing, related or negotiated prices, with Oracle paying up to 0.50% commission on each share sold. Net proceeds are intended for general corporate purposes, including capital spending, debt repayment, investments or acquisitions, and dividends or share repurchases. Oracle had 2,872,573,090 shares outstanding as of November 30, 2025, providing context for potential dilution from future issuances under this program.